WOBURN, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- Curiox Biosystems today announced the signing of a Master Software License Agreement with a major global pharmaceutical organization for the ...

Leading AI-Powered Immune Profiling Company IMU to Adopt Pluto Workstation for Large-Scale Immune Phenotyping Project Based on UK Patient Big Data SEOUL, South Korea, May 15, 2025 (GLOBE NEWSWIRE) -- ...

SEOUL, SOUTH KOREA, Aug. 14, 2023 /PRNewswire/ -- Curiox Biosystems Inc., a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis ...

Find the Curiox BioSystems financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial reports, including the ...

The share price of Curiox Biosystems has surged significantly this year. Despite expectations of a large operating loss again this year, the company's corporate value is rising on the back of strong ...

Curiox Biosystems, a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis, is pleased to announce its collaboration with Dr.

Curiox BioSystems (445680) has delivered a 54% change over the past year, with a 52-week range between 32,550 and 149,200. What Is the Average Daily Trading Volume of Curiox BioSystems (445680)? The ...

First master licensing framework for Pluto Code enables a global pharmaceutical organization to expand centrifuge-free automation across its liquid-handling infrastructure without repeated contracting ...

Curiox Biosystems Co. Ltd. Curiox Biosystems Co., Ltd. engages in the sale of automated equipment and consumables for cell analysis processes. Its products include cell pre-processing automation ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...